about
Itraconazole, a commonly used antifungal, inhibits Fcγ receptor-mediated phagocytosis: alteration of Fcγ receptor glycosylation and gene expressionSafety, pharmacokinetics, and pharmacodynamics of cyclodextrin itraconazole in pediatric patients with oropharyngeal candidiasisMechanisms of pharmacokinetic and pharmacodynamic drug interactions associated with ritonavir-enhanced tipranavir.Human pharmacogenomic variations and their implications for antifungal efficacy.Role of itraconazole in haematology/oncology.Malignant otitis externa due to Aspergillus niger.Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent.Itraconazole (Sporanox) in superficial and systemic fungal infections.New developments in antifungal strategy.A d-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients.Soluble itraconazole in tablet form using disordered drug delivery approach: critical scale-up considerations and bio-equivalence studies.Antifungal prophylaxis following reduced-intensity stem cell transplantation.A mucoadhesive, cyclodextrin-based vaginal cream formulation of itraconazole.Pediatric antifungal agents.Antigen negative gastrointestinal histoplasmosis in an AIDS patientRisk of azole-enhanced vincristine neurotoxicity in pediatric patients with hematological malignancies: old problem - new dilemma.Oral antifungal therapy for chronic rhinosinusitis and its subtypes: a systematic review.Antifungal therapy in children: an update.Antifungal agents in current pediatric practice.Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.Efficacy and safety of itraconazole use in infants.Population In Vitro-In Vivo Correlation Model Linking Gastrointestinal Transit Time, pH, and Pharmacokinetics: Itraconazole as a Model Drug.Pharmacokinetics of Azole Antifungals in Cystic Fibrosis.Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children.Successful empirical antifungal therapy of intravenous itraconazole with pharmacokinetic evidence in pediatric cancer patients undergoing hematopoietic stem cell transplantation.Pharmacological agents in development for invasive aspergillosis.Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogsPharmacokinetics and Relative Bioavailability of Orally Administered Innovator-Formulated Itraconazole Capsules and Solution in Healthy Dogs.Comparison of itraconazole and fluconazole treatments in a murine model of coccidioidal meningitis.Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol Dispersing.Drug-drug interaction between itraconazole and the protease inhibitor lopinavir/ritonavir.In vitro susceptibility of dermatophytes isolated from patients with end-stage renal disease: a case-control study.A randomized, double-blind, placebo-controlled study of itraconazole capsules for the prevention of deep fungal infections in immunodeficient patients with HIV infection.Cabergoline plasma concentration is increased during concomitant treatment with itraconazole.Drug-drug interaction between itraconazole and the antiretroviral drug lopinavir/ritonavir in an HIV-1-infected patient with disseminated histoplasmosis.Clinical evidence of interaction between itraconazole and nonnucleoside reverse transcriptase inhibitors in HIV-infected patients with disseminated histoplasmosis.New agents for the treatment of systemic fungal infections--current status.High payload itraconazole-incorporated lipid nanoparticles with modulated release property for oral and parenteral administration.
P2860
Q33810233-02079013-31B7-4041-B195-62E380D94EB2Q34111158-E620BB15-CFD5-4B39-ADFB-8B8CA444F199Q34633457-D7592021-A099-4D4E-B438-7189582333EEQ35070838-3ECFF818-2045-458E-98AF-335369E60932Q35070963-1AF26153-08DF-4588-9E63-DAB28D5226BEQ35168354-13C02A29-C223-4E5D-AC56-6C7C28B605F6Q35685548-759A9B00-F8A2-479B-B682-DC41EE694320Q35831839-A4CAA0AB-14BE-4D34-98CB-F8A91EBCD86DQ35917270-27990F70-BD31-4603-ABE9-4B2CF178DCB4Q35917388-02F23118-3D20-4543-8A27-AECE5C07EF91Q36388027-CFBC6E09-80F8-49B2-9491-652A1F7A9120Q36636520-29130E6D-D4BB-4721-955E-92716EA191B9Q36658236-52E0A094-FA14-4456-962B-65FE174FBE50Q37361968-AA89B771-C43D-4DC6-BF0F-A410EBC7262FQ37594515-58F4006F-53F6-43B0-AC87-3011D0ED5D0AQ37619670-91D630D1-7C24-4ADC-9188-7CF4C7AFD827Q37832214-E3D71553-EA5E-4D5A-8EF7-173F0A7B6AC6Q37979762-A88B0055-C30D-4526-A6FC-4CE24651BF14Q38015090-2C8B5704-2175-4495-88C8-21610030B543Q38101520-C77207B0-0785-494E-A5BE-1DA5589D5FCCQ38193337-E3C9DEC1-408C-43EA-9522-35796EBE92DBQ38681635-2A671FF0-039B-4F4C-8B84-1FF2D6878368Q38861365-354E7B8D-AFAA-4418-8187-238050A11D8CQ39817720-523745F5-97ED-4BBC-9881-26AA0508F2A9Q40099220-16EB82A0-24C2-4118-ADE6-075EA127DFFFQ40119390-37B03500-E747-4116-8F5D-8C3CAD2E338FQ40153913-036FC83B-BD77-424C-B432-EABE9126801BQ40409386-6096334F-B714-4D23-9694-43CD8E6770DBQ40851361-AF84E7E1-2125-497B-A5EC-ED634287EB9DQ41001936-41430B58-53E9-4A36-A89A-AF927D8629F0Q42554139-097547B6-545A-4177-AC42-19AA24E59431Q43119931-2C62880D-5B6F-4D27-8920-D5503A376BA7Q43236620-6DED7112-B730-4BCB-8372-0375CDCF0436Q43753731-D79B7C44-0AB8-4E77-A3CA-2536AAF34F62Q43818097-E1FF9CB8-4FC3-47F5-A10B-3D8619CB4768Q44237912-8287E878-10C7-427E-BCEF-6AC9D6447C5BQ44850148-7AB533EB-F1A2-4704-8F16-6E33C39571C2Q46032916-23C7520F-A157-4874-95EC-2B01038AB499Q46576615-6C7D9599-06CD-4657-AFE7-11EDA84B36EFQ48260826-501CB8AA-F215-46B2-B9FA-FAAC5A70EA7F
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pharmacology of itraconazole.
@ast
Pharmacology of itraconazole.
@en
type
label
Pharmacology of itraconazole.
@ast
Pharmacology of itraconazole.
@en
prefLabel
Pharmacology of itraconazole.
@ast
Pharmacology of itraconazole.
@en
P1433
P1476
Pharmacology of itraconazole.
@en
P2093
De Beule K
Van Gestel J
P356
10.2165/00003495-200161001-00003
P478
61 Suppl 1
P577
2001-01-01T00:00:00Z
P6179
1018579186